拓斯達(300607.SZ):擬建拓斯達智能設備總部基地項目
格隆匯 8 月 19日丨拓斯達(300607.SZ)公佈,公司擬與廣東省東莞市大嶺山鎮人民政府簽訂《拓斯達智能設備總部基地項目投資協議》,就公司擬在東莞市大嶺山鎮連平畔山工業園進行的拓斯達智能設備總部基地建設達成協議。項目分多期投資,項目建成後,將進一步擴大公司的產品生產規模,豐富產品結構,提升公司的核心競爭力和盈利能力。
項目主要內容:工業機器人、注塑設備、CNC設備等智能製造高端裝備的研發和製造。項目建設期限:項目建設工期為24個月。其中,首宗用地在2021年6月前動工建設。項目應於2023年12月前投產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.